Contact
Please use this form to send email to PR contact of this press release:
Intra-Cellular Therapies Announces FDA Acceptance of New Drug Application for Lumateperone for the Treatment of Schizophrenia
TO:
Please use this form to send email to PR contact of this press release:
Intra-Cellular Therapies Announces FDA Acceptance of New Drug Application for Lumateperone for the Treatment of Schizophrenia
TO: